Honorary Professor

Grant Ramm

Email: 

Availability

Honorary Professor Grant Ramm is:
Available for supervision

Fields of research

Clinical sciences

Qualifications

  • Bachelor (Honours), The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Search Professor Grant Ramm’s works on UQ eSpace

187 works between 1985 and 2025
All (187) Journal Article (143) Conference Publication (44)

141 - 160 of 187 works

2004

Journal Article

Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease

Pereira, Tamara N., Lewindon, Peter J., Smith, Jeffery L., Murphy, Therese L., Lincoln, Douglas J., Shepherd, Ross W. and Ramm, Grant A. (2004). Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease. Journal of Hepatology, 41 (4), 576-583. doi: 10.1016/j.jhep.2004.06.032

Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease

2004

Conference Publication

Signals for hepatic figrogenesis in pediatric cholestatic liver disease: Review and hypothesis

Ramm, G. A., Hoskins, A. C., Greco, S. A., Pereira, T. N. and Lewindon, P. J. (2004). Signals for hepatic figrogenesis in pediatric cholestatic liver disease: Review and hypothesis. 11th International Symposium on the Cells of the Hepatic Sinusoid and their Relation to Other Cells, Tucson, Arizona, U.S.A., 25–29 August 2002. London, United Kingdom: BioMed Central. doi: 10.1186/1476-5926-2-S1-S5

Signals for hepatic figrogenesis in pediatric cholestatic liver disease: Review and hypothesis

2003

Journal Article

A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient

ArdenKE, WallaceDF, DixonJL, SummervilleL, SearleJW, AndersonGJ, RammGA, PowellLW and Subramaniam, V. N. (2003). A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient. Gut, 52 (8), 1215-1217. doi: 10.1136/gut.52.8.1215

A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient

2003

Journal Article

Identification and characterization of the hepatic stellate cell transferrin receptor

Bridle, Kim R., Crawford, Darrell H. G. and Ramm, Grant A. (2003). Identification and characterization of the hepatic stellate cell transferrin receptor. American Journal of Pathology, 162 (5), 1661-1667. doi: 10.1016/S0002-9440(10)64300-3

Identification and characterization of the hepatic stellate cell transferrin receptor

2003

Journal Article

Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis

Bridle, K. R., Frazer, D. M., Wilkins, S. J., Dixon, J. L., Purdie, D. M., Crawford, D. H. G., Subramaniam, V. N, Powell, L. W., Anderson, G. J. and Ramm, G. A. (2003). Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet, 361 (9358), 669-673. doi: 10.1016/S0140-6736(03)12602-5

Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis

2003

Journal Article

Evidence for a sub-morphological inflammatory process in the liver in haemochromatosis

Bridle, K. R., Crawford, D. H. G., Fletcher, L. M., Smith, J. L., Powell, L. W. and Ramm, G. A. (2003). Evidence for a sub-morphological inflammatory process in the liver in haemochromatosis. Journal of Hepatology, 38 (4), 426-433. doi: 10.1016/S0168-8278(02)00444-0

Evidence for a sub-morphological inflammatory process in the liver in haemochromatosis

2002

Journal Article

The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease

Lewindon, PJ, Pereira, TN, Hoskins, AC, Bridle, KR, Williamson, RM and Ramm, GA (2002). The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease. American Journal of Pathology, 160 (5), 1705-1715. doi: 10.1016/S0002-9440(10)61117-0

The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease

2001

Journal Article

Role of myofibroblasts in tumour encapsulation of hepatocellular carcinoma in haemochromatosis

Bridle, Kim R., Crawford, Darrell H. G., Powell, Lawrie W. and Ramm, Grant A. (2001). Role of myofibroblasts in tumour encapsulation of hepatocellular carcinoma in haemochromatosis. Liver, 21 (2), 96-104. doi: 10.1034/j.1600-0676.2001.021002096.x

Role of myofibroblasts in tumour encapsulation of hepatocellular carcinoma in haemochromatosis

2001

Journal Article

HPP1: A transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers

Young, J. P., Biden, K. G., Simms, L. A., Huggard, P. R., Karamatic, R., Eyre, H. J., Sutherland, G. R., Herath, N. I., Barker, M. A., Anderson, G. J., Fitzpatrick, D. R., Ramm, G. A., Jass, J. R. and Leggett, B. A. (2001). HPP1: A transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. Proceedings of the National Academy of Sciences of the United States of America, 98 (1), 265-270. doi: 10.1073/pnas.011415298

HPP1: A transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers

2001

Journal Article

Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3

Macdonald, G., Bridle, K. R., Ward, P. J., Walker, N. I., Houglum, K., George, D. K., Smith, J. L., Powell, L. W., Crawford, D. and Ramm, G. A. (2001). Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3. Journal of Gastroenterology and Hepatology, 16 (6), 599-606. doi: 10.1046/j.1440-1746.2001.02445.x

Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3

2001

Conference Publication

Hepatic expression of iron transporters in patients with hemochromatosis or hepatitis C virus infection

Brindle, K.R., Frazer, D.M., Crawford, D.H. and Ramm, G.A. (2001). Hepatic expression of iron transporters in patients with hemochromatosis or hepatitis C virus infection. 52th Annual Meeting of the American Association for the Study of Liver Diseases, Dallas, TX, United States, 9-13 November 2001. Hoboken, NJ, United States: John Wiley & Sons.

Hepatic expression of iron transporters in patients with hemochromatosis or hepatitis C virus infection

2000

Conference Publication

Cystic fibrosis liver disease and liver biopsy: improved accuracy of assessment with dual sampling

Lewindon, P. J., Walker, N. I., Williamson, R., Smith, J. L., Pereira, T. N., Shepherd, R. W. and Ramm, G. A. (2000). Cystic fibrosis liver disease and liver biopsy: improved accuracy of assessment with dual sampling. Australian Gastroenterology Week 2000, Hobart, 18-21 Oct, 2000. Asia: Blackwell Science.

Cystic fibrosis liver disease and liver biopsy: improved accuracy of assessment with dual sampling

1999

Journal Article

Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis

Haber, P. S., Keogh, G. W., Apte, M. V., Moran, C. S., Stewart, N. L., Crawford, D. H. G., Pirola, R. C., McCaughan, G. W., Ramm, G. A. and Wilson, J. S. (1999). Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. American Journal of Pathology, 155 (4), 1087-1095. doi: 10.1016/S0002-9440(10)65211-X

Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis

1999

Journal Article

Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis

George, D. Keith, Ramm, Grant A., Walker, Neal I., Powell, Lawrie W. and Crawford, Darrell H. G. (1999). Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis. Journal of Hepatology, 31 (1), 47-52. doi: 10.1016/S0168-8278(99)80162-7

Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis

1999

Conference Publication

Activated hepatic stellate cells produce increased collagen type I in patients with cystic fibrosis liver disease

Smith, J. L., Ramm, G. A., Lewindon, P. and Blanch, N. L. (1999). Activated hepatic stellate cells produce increased collagen type I in patients with cystic fibrosis liver disease. Basel, Switzerland, Oct 1999. Switzerland: Congress for Liver Disease.

Activated hepatic stellate cells produce increased collagen type I in patients with cystic fibrosis liver disease

1999

Journal Article

Genetics of hemochromatosis

Cullen, L. M., Anderson, G. J., Ramm, G. A., Jazwinska, E. C. and Powell, L. W. (1999). Genetics of hemochromatosis. Annual Review of Medicine, 50 (1), 87-98. doi: 10.1146/annurev.med.50.1.87

Genetics of hemochromatosis

1999

Conference Publication

Hepatic stellate cells and hepatic fibrogenesis in cystic fibrosis liver disease

Greco, S., Lewindon, P., Ramm, G. A. and Shepherd, R. W. (1999). Hepatic stellate cells and hepatic fibrogenesis in cystic fibrosis liver disease. Thirteenth Annual North American Cystic Fibrosis Conference, Washington State Convention and Trade Cen., Seattle, Washington USA, 7 - 10 October, 1999. California, USA: Wiley-Liss. doi: 10.1002/(SICI)1099-0496(199909)28:19

Hepatic stellate cells and hepatic fibrogenesis in cystic fibrosis liver disease

1999

Conference Publication

Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases

Ramm, G. A., Murphy, T. L., Fanning, P. A., Clouston, A. D., George, D. K., Fletcher, L. M., Anderson, G., Powell, L. W. and Crawford, D. H. (1999). Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases. Bioiron'99, Sorrento Palace, Sorrento - Naples, Italy, 23 - 28 May 1999. Italy: SGC.

Serum collagen type IV and hyaluronic acid as markers of hepatic fibrosis in patients with haemochromatosis and other chronic liver diseases

1999

Conference Publication

Hepatic fibrogenesis in cystic fibrosis liver disease

Blanch, N. L., Bridle, K., Greco, S., Lewindon, P., Murphy, T. M., Pereira, T., Ramm, G. A., Shepherd, R. W., Smith, J. L. and Walker, N. I. (1999). Hepatic fibrogenesis in cystic fibrosis liver disease. 50th Annual Meeting and Postgraduate Conference, Dallas, Texas, Nov 1999. USA: Harcourt and Brace (WD Saunders).

Hepatic fibrogenesis in cystic fibrosis liver disease

1999

Conference Publication

Identification and characterisation of the hepatic stellate cell transferrin receptor and influence of transferrin on hepatic stellate cell activation

Bridle, K., Stewart, N. L., Crawford, D. H., Anderson, G. and Ramm, G. A. (1999). Identification and characterisation of the hepatic stellate cell transferrin receptor and influence of transferrin on hepatic stellate cell activation. Bioiron'99, Sorrento Palace, Sorrento-Naples, Italy, 23 - 28 May 1999. Italy: SGC.

Identification and characterisation of the hepatic stellate cell transferrin receptor and influence of transferrin on hepatic stellate cell activation

Past funding

  • 2018 - 2020
    Tissue ferritin is a damage-associated molecular pattern (DAMP) in inflammasome-induced inflammation associated with hepatic stellate cell activation and ... (NHMRC Project Grant led by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2016 - 2020
    SARA: Delineating its Association with the Onset and Development of Liver Fibrosis (NHMRC Project Grant led by Queensland University of Technology)
    Queensland University of Technology
    Open grant

Availability

Honorary Professor Grant Ramm is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Completed supervision

Enquiries

For media enquiries about Honorary Professor Grant Ramm's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au